Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Institut De Recherches Internationales Servier

Clinical trials sponsored by Institut De Recherches Internationales Servier, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 3 Terminated 1

Targeted combo attack: new hope for advanced bile duct cancer?

Disease control Recruiting now

This study tests a new combination of drugs (ivosidenib, durvalumab, and chemotherapy) as a first treatment for people with advanced bile duct cancer that has a specific IDH1 gene mutation. The goal is to see if the combination is safe and shrinks tumors. About 52 adults with ino…

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated Apr 29, 2026 02:07 UTC